STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
PHASE2
To learn if the drug combination of tiragolumab and ivonescimab can help to...
An Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Gastric or Gastroesophageal Junction Carcinoma
PHASE1
This is a Phase Ib/II, open-label, multicenter, randomized umbrella study i...
Status
Terminated
Location
The General Hospital of People?s Liberation Army (301 Hospital)
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
PHASE1
This is a Phase Ib/II, open-label, multicenter, randomized umbrella study i...
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
PHASE2
This study will evaluate the surgical safety and feasibility of atezolizuma...
A Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Participants With Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma
PHASE2
This study will evaluate the safety of tobemstomig (RO7247669) in combinati...
A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary
PHASE2
The goal of this clinical research study is to learn if the combination of ...
Status
Active Not Recruiting
Location
The University of Texas M. D. Anderson Cancer Center